Noninvasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia Using Cell-Free Fetal DNA in Maternal Plasma
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
CONTEXT: Congenital adrenal hyperplasia (CAH) is an autosomal recessive condition that arises from mutations in CYP21A2 gene, which encodes for the steroidogenic enzyme 21-hydroxylase. To prevent genital ambiguity in affected female fetuses, prenatal treatment with dexamethasone must begin on or before gestational week 9. Currently used chorionic villus sampling and amniocentesis provide genetic results at approximately 14 weeks of gestation at the earliest. This means that mothers who want to undergo prenatal dexamethasone treatment will be unnecessarily treating seven of eight fetuses (males and three of four unaffected females), emphasizing the desirability of earlier genetic diagnosis in utero. OBJECTIVE: The objective of the study was to develop a noninvasive method for early prenatal diagnosis of fetuses at risk for CAH. PATIENTS: Fourteen families, each with a proband affected by phenotypically classical CAH, were recruited. DESIGN: Cell-free fetal DNA was obtained from 3.6 mL of maternal plasma. Using hybridization probes designed to capture a 6-Mb region flanking CYP21A2, targeted massively parallel sequencing (MPS) was performed to analyze genomic DNA samples from parents and proband to determine parental haplotypes. Plasma DNA from pregnant mothers also underwent targeted MPS to deduce fetal inheritance of parental haplotypes. RESULTS: In all 14 families, the fetal CAH status was correctly deduced by targeted MPS of DNA in maternal plasma, as early as 5 weeks 6 days of gestation. CONCLUSIONS: MPS on 3.6 mL plasma from pregnant mothers could potentially provide the diagnosis of CAH, noninvasively, before the ninth week of gestation. Only affected female fetuses will thus be treated. Our strategy represents a generic approach for noninvasive prenatal testing for an array of autosomal recessive disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Noninvasive cell-free fetal DNA testing enables fetal sex determination and genotyping as early as 4–5 weeks of gestation, allowing prenatal therapy to be limited to affected females only (16, 100).”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [100]
In the citing paper
“Prenatal sex typing (SRY detection) can be performed using PCR amplification of cell-free fetal DNA as early as week 6-9 (323)”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [323]
In the citing paper
“By using blood from both parents and an affected proband and applying massively parallel DNA sequencing coupled with extensive analysis of single nucleotide polymorphisms near the CYP21A2 gene, it was possible to determine the CYP21A2 genotype in 14 of 14 at-risk fetuses within 3 weeks of obtaining fetal DNA in maternal blood samples (99).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [99]
Citations
Cites
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468 · cited 5×
“E1028 New et al Noninvasive CAH Diagnosis Using Maternal Plasma DNA J Clin Endocrinol Metab, June 2014, 99(6):E1022–E1030”
MethodInfluentialMaternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus
Lo, Y. M. D., Chan, K. C. A., Sun, H., Chen, E. Z., Jiang, P., Lun, F. M. F., Zheng, Y. W., Leung, T. Y., Lau, T. K., Cantor, C. R., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001720 · Cited by 1,101 · cited 12×
“Notably, to determine inheritance, we carried out relative haplotype dosage analysis (RHDO) (7, 8) to establish overrepresentation of the maternal and paternal haplotypes in the pregnant mother’s plasma with reference to the respective noninherited haplotypes.”
MethodSelf-citationProcedure-Related Complications of Amniocentesis and Chorionic Villous Sampling: A Systematic Review
Mujezinovic, F., & Alfirevic, Z. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000278820.54029.e3 · Cited by 446
Digital PCR for the molecular detection of fetal chromosomal aneuploidy
Lo, Y. M. D., Lun, F. M. F., Chan, K. C. A., Tsui, N. B. Y., Chong, K. C., Lau, T. K., Leung, T. Y., Zee, B. C. Y., Cantor, C. R., & Chiu, R. W. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705765104 · Cited by 434 · cited 11×
“We thus proceeded to investigate in silico the effects of varying fractional fetal DNA concentrations on the SPRT analysis (see Supplemental Methods and Supplemental Table 3).”
MethodSelf-citationPang, S., Wallace, M. A., Hofman, L., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)42164-1 · Cited by 392 · cited 1×
“Affecting 1 of 15 000 live births worldwide (1, 2), the disease is characterized by varying levels of impairments in mineralocorticoid and glucocorticoid synthesis, over-”
BackgroundNew, M. I., Abraham, M., Gonzalez, B., Dumic, M., Razzaghy-Azar, M., Chitayat, D., Sun, L., Zaidi, M., Wilson, R. C., & Yuen, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300057110 · Cited by 365 · cited 5×
“Remarkably, both children had the same mutation, del/ V281L, but had variable phenotypes (2, 4).”
BackgroundSelf-citationWhere the crossovers are: recombination distributions in mammals
Kauppi, L., Jeffreys, A. J., & Keeney, S. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1346 · Cited by 307 · cited 1×
“These results could most likely be explained by a recombination event in a major histocompatibility complex class II recombination hot spot (12, 13), which we confirmed with targeted MPS on the newborn’s DNA.”
BackgroundTsui, N. B. Y., Kadir, R. A., Chan, K. C. A., Chi, C., Mellars, G., Tuddenham, E. G., Leung, T. Y., Lau, T. K., Chiu, R. W. K., & Lo, Y. M. D. (2011) · Blood · doi:10.1182/blood-2010-10-310789 · Cited by 260 · cited 1×
“(21), cystic fibrosis (22), and Gaucher disease (23).”
BackgroundSelf-citationPang, S., Wallace, M. A., Hofman, L. F., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · PEDIATRICS · doi:10.1542/peds.81.6.866 · Cited by 191
Lam, K.-W. G., Jiang, P., Liao, G. J. W., Chan, K. C. A., Leung, T. Y., Chiu, R. W. K., & Lo, Y. M. D. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.189589 · Cited by 189 · cited 13×
“ssemia (8), 11 -hydroxylase deficiency (20), hemophilia”
MethodSelf-citation
Cited by
Items 101–200 of 325
New trend in non-invasive prenatal diagnosis
Ferrari, M., Carrera, P., Lampasona, V., & Galbiati, S. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.12.026 · Cited by 20
Noninvasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia
Khattab, A., Yuen, T., Sun, L., Yau, M., Barhan, A., Zaidi, M., Lo, Y. M. D., & New, M. I. (2015) · Endocrine development · doi:10.1159/000439326 · Cited by 20
Self-citationErlich, H. A., López-Peña, C., Carlberg, K. T., Shih, S., Bali, G. K., Yamaguchi, K. D., Salamon, H., Das, R., Lal, A., & Calloway, C. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab118 · Cited by 18
Congenital Adrenal Hyperplasia
Speiser, P. (2015) · F1000Research · doi:10.12688/f1000research.6543.1 · Cited by 22
Bolnick, A. D., Fritz, R., Jain, C. V., Kadam, L., Bolnick, J. M., Kilburn, B. A., Singh, M., Diamond, M. P., Drewlo, S., & Armant, D. R. (2016) · Reproductive Sciences · doi:10.1177/1933719116632922 · Cited by 19
“The possibility of diagnosing 21-OHD mutations by massively parallel sequencing of cellfree fetal DNA in maternal blood has been tested with success prior to 7 weeks gestation.(15) The approach requires adequate read depth and genomic coverage to establish the fetal genotype.”
BackgroundYin, X., Du, Y., Zhang, H., Wang, Z., Wang, J., Fu, X., Cui, Y., Chen, C., Liang, J., Xuan, Z., et al. (2018) · Journal of Human Genetics · doi:10.1038/s10038-018-0489-9 · Cited by 18
Defects of Adrenal Steroidogenesis
Yau, M., Khattab, A., Pina, C., Yuen, T., Meyer‐Bahlburg, H. F. L., & New, M. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00104-9 · Cited by 20
Self-citationLinking the degree of virilization in females with congenital adrenal hyperplasia to genotype
Gurgov, S., Bernabé, K. J., Stites, J., Cunniff, C. M., Lin‐Su, K., Felsen, D., New, M. I., & Poppas, D. P. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13370 · Cited by 17
Self-citationCongenital adrenal hyperplasia
Simpson, H., & Hughes, I. A. (2017) · Medicine · doi:10.1016/j.mpmed.2017.05.012 · Cited by 18
New developments in prenatal diagnosis of congenital adrenal hyperplasia
Kazmi, D., Bailey, J., Yau, M. L., Abu‐Amer, W., Kumar, A., Low, M., & Yuen, T. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.06.016 · Cited by 17
Self-citationCOFFEE: control‐free noninvasive fetal chromosomal examination using maternal plasma DNA
Sun, K., Chan, K. C. A., Hudecova, I., Chiu, R. W. K., Lo, Y. M. D., & Jiang, P. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5016 · Cited by 17
Self-citationHan, L., Chen, C., Guo, F., Ye, J., Peng, Z., Qiu, W., Wang, Y., Li, W., Zhang, H., Liang, L., et al. (2019) · Prenatal Diagnosis · doi:10.1002/pd.5601 · Cited by 16
Heland, S., Hewitt, J. K., McGillivray, G., & Walker, S. P. (2016) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12423 · Cited by 16
(2017) · PubMed · doi:10.17458/per.vol15.2017.rvc.prenataltreatment · Cited by 16
Zhang, S., Han, S., Zhang, M., & Wang, Y. (2018) · Legal Medicine · doi:10.1016/j.legalmed.2018.03.009 · Cited by 18
Li, H., Du, B., Jiang, F., Guo, Y., Wang, Y., Zhang, C., Zeng, X., Xie, Y., Ouyang, S., Xian, Y., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.963 · Cited by 22
“Various diseases for which this NIPD strategy has been adopted include cystic fibrosis (Bustamante‐Aragones et al., 2008), congenital adrenal hyperplasia (CAH) (Chiu et al., 2002), and thalassemia (Xiong et al., 2015; Zafari et al., 2016).”
BackgroundInfluentialPacault, M., Verebi, C., Lopez, M., Vaucouleur, N., Orhant, L., Deburgrave, N., Leturcq, F., Vidaud, D., Girodon, E., Bienvenu, T., et al. (2022) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17201 · Cited by 20
Rather, R. A., & Saha, S. C. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13923 · Cited by 16
Dörr, H. G., Binder, G., Reisch, N., Gembruch, U., Oppelt, P. G., Wieacker, P. F., & Kratzsch, J. (2015) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0041-109717 · Cited by 20
“In the study by New et al., the earliest time of diagnosis was the 6th week of gestation; based on the results of the diagnostic procedure, pre-natal therapy was initiated even prior to the 9th week [9].”
BackgroundMethodCongenital Adrenal Hyperplasia
Yau, M., Pina, C., Khattab, A., & New, M. I. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0002261.pub2 · Cited by 15
Self-citationThe Adrenal Cortex and Its Disorders
Hughes, C. R., Man, E., & Achermann, J. C. (2019) · Wiley eBooks · doi:10.1002/9781119152712.ch9 · Cited by 19
Li, C., Xiong, M., Zhan, Y., Zhang, J., Qiao, G., Li, J., & Hong, Y. (2023) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-023-00674-x · Cited by 14
Noninvasive Prenatal Testing: Implications for Muslim Communities
Haidar, H., Rispler‐Chaim, V., Hung, A., Chandrasekharan, S., & Ravitsky, V. (2015) · AJOB Empirical Bioethics · doi:10.1080/23294515.2014.993101 · Cited by 14
“Such tests may become clinically available in the future (New et al. 2014).”
BackgroundNoninvasive prenatal testing beyond genomic analysis
Hui, W. W. I., & Chiu, R. W. K. (2016) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000252 · Cited by 14
Self-citationRodríguez, A., Ezquieta, B., Labarta, J. I., Clemente, M., Espino, R., Rodriguez, A., & Escribano, A. (2017) · Anales de Pediatría · doi:10.1016/j.anpedi.2016.12.002 · Cited by 21
Congenital Adrenal Hyperplasia: Diagnosis and Emergency Treatment
Yau, M., Gujral, J., & New, M. I. (2015) · Europe PMC (PubMed Central) · Cited by 14
Self-citationCariati, F., Savarese, M., D’Argenio, V., Salvatore, F., & Tomaiuolo, R. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0147 · Cited by 14
Non-invasive prenatal diagnosis (NIPD): current and emerging technologies
Hanson, B., Paternoster, B., Povarnitsyn, N., Scotchman, E., Chitty, L. S., & Chandler, N. J. (2023) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2022.44 · Cited by 14
Pacault, M., Verebi, C., Champion, M., Orhant, L., Perrier, A., Girodon, E., Leturcq, F., Vidaud, D., Férec, C., Bienvenu, T., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280976 · Cited by 13
“Previous reports have used a minimum interSNP distance threshold of 200 base pairs (bp) to minimize the risk of linkage between two SNPs and a resulting bias that would hinder allelic dosage analysis, but may also discard positions that would be informative [18, 19].”
MethodAnophthalmia including next-generation sequencing-based approaches
Harding, P., Brooks, B. P., FitzPatrick, D. R., & Moosajee, M. (2019) · European Journal of Human Genetics · doi:10.1038/s41431-019-0479-1 · Cited by 13
Management of congenital adrenal hyperplasia: beyond conventional glucocorticoid therapy
Khattab, A., & Marshall, I. H. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000780 · Cited by 14
“To this end, the benefit of prenatal dexamethasone therapy versus the risk of associated potential effects of fetal exposure to dexamethasone may be justified if therapy was only directed to the CAH-affected female fetus [7,31].”
Self-citationPrenatal Genetic Testing and Screening
den Veyver, I. B. V. (2018) · Springer eBooks · doi:10.1007/978-3-319-89866-7_5 · Cited by 13
Concolino, P., & Falhammar, H. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf018 · Cited by 12
“In all 14 families, the fetal CAH status was correctly determined by 5 weeks and 6 days of gestation [87].”
Wu, W., Zhou, X., Jiang, Z., Zhang, D., Yu, F., Zhang, L., Wang, X., Chen, S., & Xu, C. (2022) · Human Genomics · doi:10.1186/s40246-022-00400-4 · Cited by 12
“Targeted RHDO analysis has been previously reported to detect parental mutations in β-thalassemia, hemophilia, congenital adrenal hyperplasia (CAH), Ellis-van Creveld syndrome (EVC), and Hunter syndrome [21, 25, 35].”
BackgroundSun, X., Lu, J., & Ma, X. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215368 · Cited by 12
Russo, C. D., Cesta, A., Longo, S. A., Barone, M. A., Cima, A., Mesoraca, A., Sparacino, D., Viola, A., & Giorlandino, C. (2019) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2019.02.010 · Cited by 12
Cost-effective and accurate method of measuring fetal fraction using SNP imputation
Kim, M., Kim, J.-H., Kim, K., & Kim, S. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx728 · Cited by 13
Self-citationByrou, S., Makrigiorgos, G. M., Christofides, A., Kallikas, I., Papasavva, T., & Kleanthous, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200348 · Cited by 12
Vong, J. S. L., Jiang, P., Cheng, S., Lee, W., Tsang, J. C. H., Leung, T.-Y., Chan, K. C. A., Chiu, R. W. K., & Lo, Y. M. D. (2018) · Prenatal Diagnosis · doi:10.1002/pd.5406 · Cited by 12
“To obtain increased sequencing depth of fetal cfDNA molecules specifically, we used a target capture approach with probes hybridizing to sequences on Chr6 and ChrY.32 The capture probes on chr6 would target both the fetal and maternal cfDNA molecules while the probes on ChrY were designed to target only the fetal cfDN…”
MethodSelf-citationGuissart, C., Mau‐Them, F. T., Debant, V., Viart, V., Dubucs, C., Pritchard, V., Rouzier, C., Boureau‐Wirth, A., Haquet, E., Puechberty, J., et al. (2018) · Fetal Diagnosis and Therapy · doi:10.1159/000489776 · Cited by 11
Congenital Adrenal Hyperplasia: Unresolved Issues
Yau, M., Khattab, A., Poppas, D. P., Ghizzoni, L., & New, M. I. (2016) · Frontiers of hormone research · doi:10.1159/000443919 · Cited by 12
Self-citationDevelopment of a comprehensive noninvasive prenatal test
Malcher, C., Yamamoto, G. L., Burnham, P., Ezquina, S., Lourenço, N. C. V., Balkassmi, S., Antônio, D. S. M., Hsia, G. S. P., Gollop, T. R., Pavanello, R. C. M., et al. (2018) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2017-0177 · Cited by 10
“In addition to aneuploidy detection, this strategy enabled the identification of variants associated with monogenic diseases, especially de novo variants (Lam et al., 2012; New et al., 2014; Chitty et al., 2015).”
Impact of Emerging Technologies in Prenatal Genetic CounselingPreprint
Stevens, B. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036517 · Cited by 10
Prenatal and Pregnancy Management of Congenital Adrenal Hyperplasia
Nowotny, H. F., Tschaidse, L., Auer, M. K., & Reisch, N. (2024) · Clinical Endocrinology · doi:10.1111/cen.15131 · Cited by 14
“…in genetic diagnostics, including targeted massively parallel sequencing of cell ‐ free DNA from plasma drawn from an expectant mother and SRY typing to determine sex and CYP21A1 genotype at GW 6, have not yet been successfully implemented into standard clinical practice [116, 118, 119].”
Wang, C., Tang, Y., Lee, I.-W., Chang, F.-M., Chien, C., Pan, H., & Sun, H. S. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01063-1 · Cited by 9
“The NGS-based RHDO is applied for NIPT for monogenic disorders based on analysis of SNPs in haplotype blocks, and is able to detect complex mutations in gene loci, such as CYP21A2 [56], and DMD [57].”
MethodLi, J., Lu, J., Su, F., Yang, J., Ju, J., Lin, Y., Xu, J., Qi, Y., Hou, Y., Wu, J. T., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.911369 · Cited by 9
Rodríguez, A., Ezquieta, B., Labarta, J. I., Clemente, M., Espino, R., Rodriguez, A., & Escribano, A. (2017) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2016.12.002 · Cited by 11
Chen, M., Chen, C., Li, Y., Yuan, Y., Lai, Z., Guo, F., Wang, Y., Huang, X., Li, S., Wu, R., et al. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2019.05.005 · Cited by 8
Kong, L., Li, S., Zhao, Z., Feng, J., Fu, X., Li, H., Zhu, J., Wang, Y., Tang, W., Yuan, C., et al. (2023) · Clinical Genetics · doi:10.1111/cge.14434 · Cited by 9
Self-citationOkpaise, O. O., Ahn, H., Tonni, G., & Ruano, R. (2024) · Prenatal Diagnosis · doi:10.1002/pd.6542 · Cited by 10
“New et al. 32 determined using a PCR assay with an SRY probe.”
MethodThe impact of digital DNA counting technologies on noninvasive prenatal testing
Sun, K., Jiang, P., & Chan, K. C. A. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1084227 · Cited by 8
“Besides digital PCR, the MPS could be used as a NIPT technology for a number of monogenic diseases including aand b-thalassemia [26,28], congenital adrenal hyperplasia [27,29] and Duchenne muscular dystrophy [30].”
MethodSelf-citationDecesare, J. Z. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.029 · Cited by 8
Current Advances in the Management of Congenital Adrenal Hyperplasia
Bouliari, A., Bullard, F., Lin‐Su, K., & Lekarev, O. (2024) · Advances in Pediatrics · doi:10.1016/j.yapd.2024.02.006 · Cited by 9
Nouveautés dans l’hyperplasie congénitale des surrénales
Dumeige, L., Bouvattier, C. M., & Lombès, M. (2017) · Annales d Endocrinologie · doi:10.1016/s0003-4266(17)30922-8 · Cited by 9
Congenital Adrenal Hyperplasia
Trapp, C. M., Levine, L. S., & Oberfield, S. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_14 · Cited by 8
Congenital adrenal hyperplasia
Krone, N. P., & Hughes, I. A. (2020) · doi:10.1093/med/9780198746690.003.0250 · Cited by 8
Zaninović, L., Bašković, M., Ježek, D., & Bojanac, A. K. (2023) · Diagnostics · doi:10.3390/diagnostics13020183 · Cited by 6
“The RHDO procedure does not require the knowledge of family-specific mutation and the construction of mutation-specific probes in order to perform SNP linkage analysis [21,24,31,32].”
RECENT DEVELOPMENTS IN NON-INVASIVE PRENATAL DIAGNOSIS AND TESTING
Drury, S., Hill, M. K., & Chitty, L. S. (2014) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539516000061 · Cited by 6
Yoon, J., Hwang, S., Kim, J. H., Kim, G.-H., Yoo, H., & Choi, J. (2024) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2346014.007 · Cited by 6
Chiu, R. W. K. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.936681 · Cited by 6
Self-citationHu, P., Qiao, F., Yuan, Y., Sun, R., Wang, Y., Meng, L., Lin, Y., Li, H., Wang, Y., Han, R., et al. (2017) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2017.08.020 · Cited by 5
An Introduction: Prenatal Screening, Diagnosis, and Treatment of Single Gene Disorders
Wapner, R. J., & Norton, M. E. (2021) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000660 · Cited by 5
Wang, Y., Li, S., Wu, D., & Yan, H. (2022) · Prenatal Diagnosis · doi:10.1002/pd.6137 · Cited by 5
“The equation is as follows: f = Σ2db/Σ(db + da), where f means the fractional fetal DNA concentration in maternal plasma, db means the read count of the fetal alleles inherited from the father, and da means read count of the alleles shared by the fetus and the mother in the maternal cfDNA.(9,12)”
BackgroundMethodNoninvasive prenatal prediction of fetal haplotype with Spearman rank correlation analysis model
Hanxiao, D., Sun, L., Chen, S., Yang, J., Zhang, Y., Zhang, S., Hongyan, C., Jiang, N., & Daru, L. (2022) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1988 · Cited by 5
“Following Mendelian inheritance, parental haplotype could be acquired through the genotype information of the parents and their first child (New et al., 2014).”
Self-citationFokstuen, S., Quteineh, L., Schwitzgebel, V., Köhler‐Ballan, B., Blouin, J., Abramowicz, M. J., & Nouspikel, T. P. (2023) · Clinical Genetics · doi:10.1111/cge.14399 · Cited by 5
Landscape of Adrenal Tumours in Patients with Congenital Adrenal Hyperplasia
Carşote, M., Gheorghe, A.-M., Nistor, C., Trandafir, A.-I., Sima, O.-C., Cucu, A.-P., Ciuche, A., Petrova, E. N., & Ghemigian, A. M. (2023) · Biomedicines · doi:10.3390/biomedicines11113081 · Cited by 8
“Prenatal diagnosis is also possible, underlying invasive methods such as analysis of the foetal hormones from amniotic fluid, chorionic villus sampling, and non-invasive procedures (cell-free foetal DNA from maternal blood) [1,19,20].”
MethodHypothalamic–Pituitary–Adrenal Axis: Congenital Adrenal Hyperplasia
Pasterski, V., & Hughes, I. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00070-5 · Cited by 5
El‐Mougy, F., Sharaf, S. A. E.-A., Hafez, M. M., Khattab, A., Abou‐Youssef, H. S., Elsharkawy, M., Baz, H., Ekladious, S., Fahmy, B. S., Musa, N., et al. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13540 · Cited by 5
Self-citationTardy-Guidollet, V., Menassa, R., Aubry, M. C., & Benachi, A. (2015) · Revue de médecine périnatale · doi:10.1007/s12611-015-0331-y · Cited by 5
Nonclassical Congenital Adrenal Hyperplasia and Pregnancy
Çuhacı, N., Aydın, C., Yeşilyurt, A., Pınarlı, F. A., Ersoy, R., & Çakır, B. (2015) · Case Reports in Endocrinology · doi:10.1155/2015/296924 · Cited by 4
In case you missed it: thePrenatal Diagnosiseditors bring you the most significant advances of 2014
Faas, B. H. W., Ghidini, A., Mieghem, T. V., Chitty, L. S., Deprest, J. A., & Bianchi, D. W. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4551 · Cited by 4
“version of the PGM, that is the Ion Proton, for prenatal diagnostic applications.(37,42,43) The Ion Proton is also a bench top instrument that uses the same semiconductor sequencing”
BackgroundCHANDRAN, S. R., & Loh, L. M. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1490399 · Cited by 4
“This cffDNA has a high turnover, ensuring that contamination from a previous pregnancy does not occur [16].”
BackgroundBabaei, K., Azimi–Nezhad, M., Norollahi, S. E., Vahidi, S., & Samadani, A. A. (2022) · Frontiers of Medicine · doi:10.1007/s11684-022-0948-8 · Cited by 5
Shaffer, S. K., & Stockdale, C. K. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.033 · Cited by 4
Second Trimester Pregnancy Loss
Casey, F. E. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.026 · Cited by 5
Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency
New, M. I., Lekarev, O., Jacob, M., Macdonald, A., Parsa, A. A., & Yuen, T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00031-9 · Cited by 4
Self-citationFuture of Cellular and Molecular Diagnostics
Raghavendra, P. B., & Pullaiah, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813679-9.00008-7 · Cited by 5
Byrou, S., Brouwer, R. W. W., Tomazou, M., Tamana, S., Kountouris, P., Lederer, C. W., Petrou, M., Özgür, Z., den Dekker, A. T., Azmani, Z., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020570 · Cited by 3
“Furthermore, other groups have also demonstrated that the utilization of more than 2 mL of maternal plasma for cfDNA extraction would increase the concentration of the extracted cfDNA, thus increasing the initial amount added in the amplification reaction [29,34,35].”
Fertility in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a review
Roszkowska, Z., Bobrowicz, M., Betlejewska, J., Hubska, J., Rak, B., & Ambroziak, U. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1682341 · Cited by 5
The role of cell‐free DNA in non‐invasive diagnosis of urinary tract infection
Zhao, Y., Zhang, W., Ma, Y., & Zhang, X. (2024) · UroPrecision · doi:10.1002/uro2.52 · Cited by 3
Weidler, E. M., Ochoa, B. V., & van Leeuwen, K. D. (2024) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001388 · Cited by 3
Induction and Augmentation of Labor
Goldberg, A. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.004 · Cited by 3
Molecular genetic strategy for diagnosis of congenital adrenal hyperplasia in Serbia
Ugrin, M., Milacic, I., Skakić, A., Klaassen, K., Komazec, J., Pavlović, S., & Stojiljković, M. (2017) · Genetika · doi:10.2298/gensr1702457u · Cited by 3
Caring for Patients With Congenital Adrenal Hyperplasia Throughout the Lifespan
Zwayne, N., Chawla, R., & van Leeuwen, K. D. (2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005263 · Cited by 3
Current perspective and scope of fetal therapy: part 2
Sharma, D., & Tsibizova, V. I. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1839881 · Cited by 5
“The initial data over use of cell free fetal DNA are promising, but still there is need for large-scale prospective studies for further validation [59].”
Genetics and Pathophysiology of Congenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_5 · Cited by 4
Miranda, M. C. D., Oliveira, A. C. M. D., Soares, G. J., Batatinha, J. A. P., Latronico, A. C., Mendonca, B. B., & Bachega, T. A. S. S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1770274 · Cited by 2
“Noninvasive cell-free fetal DNA testing enables fetal sex determination and genotyping as early as 4 – 5 weeks of gestation, allowing prenatal therapy to be limited to affected females only (16, 100).”
Chen, S., Wu, L., Ma, X., Guo, L., Zhang, J., Gao, H., & Zhang, T. (2024) · Medicine · doi:10.1097/md.0000000000040297 · Cited by 4
Ravichandran, L., Asha, H. S., Mathai, S., Thomas, N., & Chapla, A. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_303_23 · Cited by 3
“[58,59] Newborn Screening in CAH CAH satisfies the NBS criteria (Wilson and Junger) and is recommended with 17‑OHP measurements for first‑tier testing.”
MethodDetection of Monogenic Disorders Using Noninvasive Prenatal Screening
Taheri, M. N., Harsij, A., Askari, A., & Pourtavakoli, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-6402-0_10 · Cited by 2
Petrillo, N., Marcella, S., Sirica, R., Ianniello, M., Ruggiero, R., Mori, A., Castiello, R., Ramiro, C., D’Angelo, R., Pennacchio, G., et al. (2025) · Genes · doi:10.3390/genes16030311 · Cited by 2
“In 14 families affected by CAH due to CYP21A2 pathogenic variants, seven affected fetuses, five carriers, and two unaffected fetuses were identified as early as five weeks and six days of gestation [21].”
Overview and Principles of Pediatric Endocrinology
Sperling, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00001-4 · Cited by 3
Targeted Linked-Read Sequencing for Direct Haplotype Phasing of Parental GJB2/SLC26A4 Alleles
Gao, B., Jiang, Y. P., Han, M., Ji, X., Zhang, D., Wu, L., Gao, X., Huang, S., Zhao, C., Su, Y., et al. (2024) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2024.04.002 · Cited by 2
Circulating DNA, a Potentially Sensitive and Specific Diagnostic Tool for Future Medicine
Jiang, F., Yang, X., He, X., & Yang, M. (2019) · Dose-Response · doi:10.1177/1559325819891010 · Cited by 2
“Moreover, NIPT could be applied to monogenic diseases, like b-thalassemia, which can be detected by targeted genomic regions flanking the HBB gene(63) and congenital adrenal hyperplasia can be approached by flanking CYP21A2.(64) The diagnosis depends on 2 steps, first to determine from which parent the affected fetus…”
BackgroundKim, S., Kim, K., & Jeon, Y. J. (2020) · IEEE Access · doi:10.1109/access.2020.3000483 · Cited by 2
Self-citationPrenatal Diagnosis and Treatment in Congenital Adrenal Hyperplasia
Abalı, Z. Y., & Güran, T. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_9 · Cited by 2
Metode molekularne dijagnostike u prenatalnoj medicini
Zaninović, L., Bojanac, A. K., & Bašković, M. (2022) · Medicina Fluminensis · doi:10.21860/medflum2022_280997 · Cited by 2
“U posljednje vrijeme velik je napredak postignut u neinvazivnom testiranju monogenskih bolesti poput miotonične distrofije (78), cistične fibroze (79), beta talasemije major (80), kongenitalne adrenalne hiperplazije (81).”
BackgroundCongenital Adrenal Hyperplasia and Human Leukocyte Antigen B: A Meta-Analysis
Thibaut, D., Walter, M. R., McGonegal, C., Daniel, R., & Goodman, J. (2023) · Cureus · doi:10.7759/cureus.35900 · Cited by 2
“The identification of a carrier may prompt clinicians to obtain maternal serum for cell-free fetal DNA sequencing, a technique that can correctly deduce fetal CAH as early as five weeks and six days of gestation [30-31].”
BackgroundNoninvasive prenatal testing/screening by circulating cell-free DNA
van Riel, M., Stanley, K. E., & Vermeesch, J. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91380-5.00013-7 · Cited by 3
Prenatal diagnosis of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency
Yau, M., Pina, C., Khattab, A., Barhen, A., & New, M. I. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1035254 · Cited by 2
Self-citation
Metadata
- Authors
- New, M. I., Tong, Y. K., Yuen, T., Jiang, P., Pina, C., Chan, K. C. A., Khattab, A., Liao, G. J. W., Yau, M., Kim, S.-M., Chiu, R. W. K., Sun, L., Zaidi, M., & Lo, Y. M.
- Affiliations
- Mount Sinai Hospital (US)
- Chinese University of Hong Kong (HK)
- Corresponding author
- New, Maria I.
- Lo, Y. M.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-06-01
- Volume
- 99
- Issue
- 6
- Pages
- E1022-E1030
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4037720
- OpenAlex
- W2097351942
- Cited by
- 319
- References
- 28
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 18 · 2023: 23 · 2022: 15 · 2021: 18 · 2020: 15 · 2019: 23 · 2018: 32 · 2017: 88 · 2016: 25 · 2015: 36 · 2014: 8
- FWCI
- 49.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG040132, AG-23176, AG40132, R01AG023176)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK80459, R01DK080459)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR65932, R01AR065932)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- congenital adrenal hyperplasia, noninvasive prenatal diagnosis, cell-free fetal DNA, maternal plasma, CYP21A2, 21-hydroxylase, haplotype analysis, targeted sequencing, autosomal recessive disorder
- MeSH terms
- Adrenal Hyperplasia, Congenital, Base Sequence, Cell-Free System, DNA, DNA Mutational Analysis, Female, Fetus, Humans, Pedigree, Pregnancy, Prenatal Diagnosis, Steroid 21-Hydroxylase, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.